Sanam Loghavi, MD, The University of Texas MD Anderson Cancer Center, Houston, TX, discusses optical genome mapping as a method of detecting cryptic genetic abnormalities in acute myeloid leukemia (AML). Notably, this study detected KMT2A partial tandem duplications and NUP98 rearrangements, which may have a clinical impact. This interview took place at the 29th Congress of the European Hematology Association (EHA) in Madrid, Spain.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.

свернуть